amikacin has been researched along with Blood Poisoning in 204 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 90 (44.12) | 18.7374 |
| 1990's | 27 (13.24) | 18.2507 |
| 2000's | 32 (15.69) | 29.6817 |
| 2010's | 41 (20.10) | 24.3611 |
| 2020's | 14 (6.86) | 2.80 |
| Authors | Studies |
|---|---|
| Arabzadeh, AA; Khezrnia, SS; Mojtahedzadeh, M; Najafi, A; Najmeddin, F; Rouini, MR; Sefidani Forough, A; Shahrami, B | 1 |
| Al-Faifi, J; Ibrahim, ME | 1 |
| Assaly, R; Beran, A; Georgescu, C; Hochanadel, A; Luttmann, K; Mhanna, M; Srour, O | 1 |
| Jia, P; Jia, X; Kang, M; Li, R; Li, X; Liu, X; Xu, Y; Yang, Q; Yu, W; Zhu, Y | 1 |
| Assenga, EN; Godfrey, E; Majaliwa, E | 1 |
| Ananthamurthy, K; Aranjani, J; Chaudhari, BB; Chaudhari, P; Ghate, V; Lewis, S; Maxwell, A; Moorkoth, S | 1 |
| Chen, J; Liu, W; Zhao, F | 1 |
| Bai, Y; Fan, X; Fu, L; Tian, C; Wang, S; Xing, M; Zhao, Y | 1 |
| Cömert, B; Ergan, B; Ergün, B; Esenkaya, F; Gökmen, AN; Hanci, V; Heybeli, C; Küçük, M; Uzun, Ö; Yakar, MN | 1 |
| Jia, L; Jiang, Y; Li, X; Peng, Z; Wang, Y | 1 |
| Ceballos, J; Cortínez, L; García, A; Ibacache, M; Inojosa, R; Leguizamon, L; Maccioni, A; Meza, S; Paredes, N; Paulos, C; Ramírez, M; Severino, N; Toso, A; Urzúa, S; Von Mentlen, C | 1 |
| Bijleveld, YA; de Haan, TR; Mathôt, R; Samb, A; Sinkeler, F; van Kaam, A | 1 |
| Cermanová, J; Chládek, J; Doleželová, E; Mičuda, S; Prašnická, A; Springer, D; Studená, Š | 1 |
| Annaert, P; De Winter, S; Desmet, S; Dreesen, E; Meersseman, W; Peetermans, W; Spriet, I; Van den Eede, N; van Hest, R; Vanbrabant, P; Verelst, S; Wauters, J | 1 |
| Allegaert, K; Cristea, S; Knibbe, CAJ; Krekels, EHJ; Kulo, A; Smits, A; van Weissenbruch, M | 1 |
| Aliska, G; Azwar, MK; Dewi, TU; Karuniawati, A; Purwantyastuti, P; Sedono, R; Setiabudy, R | 1 |
| Astroza, G; Catalán, M; Cerón, I | 1 |
| Arrivé, L; Monnier-Cholley, L; Pacanowski, J; Roux, A | 1 |
| Byrne, BA; Edman, JM; Kass, PH; Magdesian, KG; Theelen, MJP; Wilson, WD | 1 |
| Ait Hamou, N; Amour, J; Bouglé, A; Dujardin, O; El-Helali, N; Lebreton, G; Lepère, V; Petijean, G; Salem, JE; Vidal, C | 1 |
| Dhareshwar, J; Gulia, S; Gupta, S; Kannan, RA; Rodrigues, C; Vora, A | 1 |
| Ahmadi, A; Mahmoudi, L; Mohammadpour, AH; Mojtahedzadeh, M; Niknam, R | 1 |
| Dwijayanti, A; Louisa, M; Rundjan, L; Setiabudy, R; Simanjuntak, E; Suwento, R; Yasin, FH | 1 |
| Fink, L; Gaylis, F | 1 |
| Healy, D; Kagan, R; Neely, A; Sherwin, CM; Spigarelli, MG; Stockmann, C; Wead, S | 1 |
| Duszynska, W; Hurkacz, M; Kowalska-Krochmal, B; Kübler, A; Taccone, FS; Wiela-Hojeńska, A | 1 |
| Bethou, A; Biswal, N; Mathai, B; Ramasamy, S | 1 |
| Samiee-Zafarghandy, S; van den Anker, JN | 1 |
| Doluoglu, OG; Eroglu, M; Ozgur, BC; Sarici, H; Telli, O | 1 |
| Jain, N; Tewari, VV | 1 |
| Brodowska-Kania, D; Dubchak, I; Gomółka, M; Jurkiewicz, D; Niemczyk, S; Piechota, W; Rymarz, A; Szamotulska, K | 1 |
| Bhat Y, R; Lewis, LE; Patra, S; Purakayastha, J; Sivaramaraju, VV | 1 |
| Garg, A; Goel, A; Nangia, S; Randhawa, VS; Saili, A; Sharma, S | 1 |
| Ahmadi, A; Ahmadvand, A; Khalili, H; Mahmoudi, L; Mojtahedzadeh, M; Najafi, A; Najmeddin, F; Sadeghi, K | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F | 1 |
| Bursle, E; Cotta, MO; Gowen, B; Lipman, J; McWhinney, B; Roberts, JA; Truloff, N; Ungerer, JP | 1 |
| Allegaert, K; Danhof, M; De Cock, RF; Knibbe, CA; Smits, A; Vanhaesebrouck, S | 1 |
| Allaouchiche, B; Evrard, A; Friggeri, A; Knani, H; Lavigne, JP; Lefrant, JY; Louart, B; Muller, L; Nucci, B; Roberts, JA; Roger, C | 1 |
| Dey, AC; Dey, SK; Hossain, MI; Mannan, MA; Shahidullah, M | 1 |
| Broadbent, RS; Medlicott, NJ; Reith, DM; Sherwin, CM; Svahn, S; Van Der Linden, A | 2 |
| Araoka, H; Baba, M; Matsuno, N; Takagi, S; Taniguchi, S; Tatsushima, K; Wake, A; Yoneyama, A | 1 |
| Cunha, CL; Fadel, MV; Leão, MT; Repka, JC | 1 |
| Estéves Jaramillo, A; Ortiz-Ibarra, FJ; Reyna-Figueroa, J | 1 |
| Khan, DA; Khan, FA; Razzaq, A; Siddiqi, A | 1 |
| Cumps, J; Delattre, IK; Dugernier, T; Jacobs, F; Laterre, PF; Musuamba, FT; Spapen, H; Taccone, FS; Verbeeck, RK; Vincent, JL; Wallemacq, PE; Wittebole, X | 1 |
| Fagnoul, D; Jacobs, F; Layeux, B; Taccone, FS; Vincent, JL | 1 |
| Delattre, IK; Jacobs, F; Laterre, PF; Musuamba, FT; Nyberg, J; Taccone, FS; Verbeeck, RK; Wallemacq, PE | 1 |
| Abdel-Hady, E; Awad, H; El Hamamsy, M; Hedaya, M | 1 |
| Çetinkaya, M; Köksal, N; Özkan, H; Sarısözen, B; Yazıcı, Z | 1 |
| Castro, J; Cornejo, R; Gálvez, R; Illanes, V; Kosche, J; Llanos, O; Luengo, C; Romero, C; Tobar, E | 1 |
| Eslamieh, H; Salamati, P; Taheri, PA | 1 |
| Taccone, FS | 1 |
| Aboussad, A; Chabaa, L; Elidrissi, NS; Issaoui, S; Maoulainine, FM; Sorra, N | 1 |
| Delattre, IK; Jacobs, F; Jacqmin, P; Laterre, PF; Musuamba, FT; Taccone, FS; Verbeeck, RK; Wallemacq, P | 1 |
| Chaffanel-Peláez, M; Del Boz, J; Serrano-Martín, MM; Vera-Casaño, A | 1 |
| Al-Maghrebi, M; Anim, JT; Kehinde, EO; Sheikh, M | 1 |
| Fredrick, F; Massawe, A; Matee, MI; Mhada, TV | 1 |
| Al Hammadi, AY; El Desoky, ES; Sheikh, AA | 1 |
| Désinor, OY; Ménos, MJ; Silva, JL | 1 |
| Ohyashiki, K | 1 |
| Adamis, T; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karayannacos, PE; Koussoulas, V; Mouktaroudi, M; Perrea, D | 1 |
| Garg, RK; Marak, RS; Ray, P; Sharma, J; Sharma, M; Singhi, S; Taneja, N | 1 |
| Antonopoulou, A; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kousoulas, V; Koutoukas, P; Panagou, C; Perrea, D; Sabracos, L | 1 |
| Ferrer, NF; Hernández, ME; Ramos, MJ | 1 |
| Adamis, T; Baziaka, F; Giamarellos-Bourboulis, E; Giamarellou, H; Karayannacos, P; Koutoukas, P; Plachouras, D; Raftogiannis, M; Sabracos, L; Tsaganos, T | 1 |
| Bramhne, HG; Chhibber, S; Sharma, S; Toky, V | 1 |
| Flidel-Rimon, O; Friedman, S; Leibovitz, E; Shinwell, ES | 1 |
| Arch, J; González, QH; Hinojosa, C; Medina-Franco, H; Orozco, H; Pantoja, JP; Sifuentes-Osornio, J; Vargas-Vorackova, F; Vilatoba, M | 1 |
| Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
| Magid, JH | 1 |
| Alexandrou, I; Chrisofos, M; Geladopoulos, T; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karagianni, V; Koussoulas, V; Koutoukas, P; Kranidioti, H; Pelekanou, E; Sabracos, L; Tsaganos, T; Tzepi, I; Vassiliadis, J | 1 |
| Chayani, N; Mahapatra, A; Mallick, B; Panda, R; Poddar, N; Roy, D; Sarangi, G | 1 |
| Aguilar-Orozco, G; Del Carmen Ramos-Jiménez, A; Guadalupe Vásquez-Mendoza, M; Romero-Gutiérrez, G; Vargas-Origel, A | 1 |
| Agrawal, C; Datta, V; Kumar, A; Mehta, G; Randhawa, VS; Saili, A | 1 |
| Ahmed, IA; Ahmed, N; El-Beshlawy, A; El-Haddad, A; El-Mahallawy, HA; Nassif, S | 1 |
| Rosoff, PM; Saini, S | 1 |
| Guevara, A; Guevara, E; Guevara, M; Medina, L; Oliveros, M; Salomón, M | 1 |
| Erdeljić, V; Francetić, I; Huić, M; Kalenić, S; Likić, R; Makar-Ausperger, K; Mercep, I; Simić, P; Tripković, V | 1 |
| Brockmeier, D; Marget, W; Roos, R; von Hattingberg, HM | 1 |
| Good, F; Harding, E; Klein, J; MacLeod, S; Perlman, M; Prober, CG; Rajchgot, P; Soldin, S | 1 |
| Mirrett, S; Reimer, LG; Reller, LB | 1 |
| Klastersky, J; Lagast, H; Meunier, F; Piccart, M; Van Laethem, Y; Weerts, D | 1 |
| Lietman, PS; Moore, RD; Smith, CR | 2 |
| Dupont, J; Fernández, A; Garay, G; López, H; Marcenac, F; Pavlovsky, S; Scaglione, C | 1 |
| Cortelezzi, A; Penagini, R; Pogliani, EM; Radaelli, F | 1 |
| Bock, BV; Edelstein, PH; Meyer, RD | 1 |
| Brin, M; Donath, J; Kennish, A; Sanders, M; Wormser, GP | 1 |
| de la Serna, JL; de Villota, ED; Diez-Balda, V; Galdos, P; Mosquera, JM; Rubio, JJ; Tomás, MI | 1 |
| Cafarelli, A; Cruciani, M; Magliulo, E; Piantieri, G | 1 |
| Yamaguchi, T | 1 |
| Berk, SL; Gage, K; Ortega, G; Vracin, W | 1 |
| Hindler, J; Martin, WJ; Meyer-Dudnik, PV; Young, LS | 1 |
| Ferrieri, P; Johnson, DE; Mitchell, C; Munson, D; Speert, DP; Thompson, TR; Wannamaker, LW | 1 |
| Belohradsky, BH; Marget, W; Roos, R | 1 |
| Cookson, B; Leung, T; Tripp, J; Williams, JD | 1 |
| Gaudry, C; Kourilsky, O | 1 |
| Aswapokee, N; Chayakul, P; Chuncharunee, S; Leelasuphasri, S; Sathapatayavongs, B; Siritanaratkul, N; Suwangool, P | 1 |
| Marik, PE | 1 |
| Beuscart, C; Mouton, YJ | 1 |
| Sjursen, H; Solberg, CO | 1 |
| Sleigh, JW | 1 |
| Castañeda-Hernández, G; Lugo, G | 2 |
| Aoki, K; Asano, S; Bessho, M; Fujita, A; Furusawa, S; Higashihara, M; Hirai, H; Hoshino, S; Hotta, T; Kitamura, K; Koike, M; Kuraishi, Y; Kurihara, I; Mizoguchi, H; Nagoshi, H; Nishimura, M; Nonaka, Y; Ohbayashi, Y; Omine, M; Oshimi, K; Ozawa, K; Suzuki, K; Takaku, F; Togawa, A; Urabe, A; Wakabayashi, Y | 1 |
| Castañeda-Hernández, G; Lugo-Goytia, G | 1 |
| Boffa, ML; De Blasi, D; Mastrullo, L; Miraglia, E; Orlando, R; Zorzato, G | 1 |
| Bourhis, Y; Cerutti, C; Ducher, M; Fauvel, JP; Foltz, F; Jelliffe, R; Maire, P; Sorensen, P | 1 |
| Jin, D; Wu, H; Wu, Z; Xu, J | 1 |
| Bal, AM; Ghadage, DP | 1 |
| Hennemann, HH | 1 |
| Hasegawa, Y; Masaoka, T; Nakamura, H; Shibata, H; Takubo, T; Ueda, T; Yoshitake, J | 1 |
| Baughman, KL; Edwards, CQ; Lietman, PS; Rogers, JF; Smith, CR | 1 |
| Axline, SG; Pesanti, EL; Rhame, FS; Yu, VL | 1 |
| Greenman, RL; Hoffman, TA; Sklaver, AR | 1 |
| Bender, JF; Fortner, CL; Hahn, DM; Love, LJ; Schimpff, SC; Standiford, HC; Wiernik, PH; Young, VM | 1 |
| Hairston, J; Sidell, J; Winston, DJ; Young, LS | 1 |
| Bodey, GP; Feld, R; Rodriguez, V; Valdivieso, M | 1 |
| Alford, RH; Leonard, JM; McGee, ZA | 1 |
| Fu, KP; Jahre, JA; Neu, HC | 1 |
| Caniggia, M; Garabedian, M; Kiegel, P; Lombard, C; Manelli, JC; Palayret, D; Perez-Cappellano, R | 1 |
| Cartier, F; Cormier, M; Dien, G; Guivarch, G; Hoel, JC | 1 |
| Berger, SA; Pollock, AA; Rahal, JJ; Richmond, AS; Simberkoff, MS | 1 |
| Arroyo, JC; Liebhaber, H; Sonnenwirth, AC | 1 |
| Black, RE; Hewitt, WL; Lau, WK; Linne, SR; Weinstein, RJ; Winston, DJ; Young, LS | 1 |
| Dupont, C; Hammerberg, S; Marks, MI; Marks, S | 1 |
| Hensgens, C; Klastersky, J; Meunier-Carpentier, F | 1 |
| Agre, K; Berman, E; Gooding, PG; Lane, AZ | 1 |
| Berger, J; Cates, CY; Fox, LM; Gurwith, MJ; Lank, BA; Mathias, RG; McCullough, DW; Ronald, AR; Stiver, HG | 1 |
| Marget, W; Reindke, B; Versmold, H | 1 |
| Guerrant, RL; Hamory, BH; Sande, MA; Strausbaugh, LJ; Wenzel, RP | 1 |
| Finegold, SM; Lewis, RP; Meyer, RD | 1 |
| Gorbach, SL; Tally, FP | 2 |
| Seneca, H | 1 |
| Kobayashi, Y; Shigeta, Y; Tomioka, H | 1 |
| Dawkins, EJ; Geheber, CE; Kolb, LD; Stone, HH | 1 |
| Becerra-Munoz, E; Bravo-Scandoval, J; Cinco-Espinoza, G; Flores-Mercado, F; Galindo-Hernandez, E; Ramirez-Jiménez, D | 1 |
| Dámaso, D; García-Iglesias, MC; Martínez-Beltrán, J; Moreno-López, M | 1 |
| Bartlett, JG; Gorbach, SL; Louie, TJ; O'Keefe, P; Tally, FP | 1 |
| Matsumoto, F; Saigusa, M; Saito, A; Ueda, Y | 1 |
| Daschner, F; Senska-Euringer, C | 1 |
| Carmalt, ED; Finegold, SM; Lewis, RP; Meyer, RD | 1 |
| Ajarim, DS; al Mohareb, F; al Momen, AK; Harakati, MS; Santhosh-Kumar, CR; Zeitany, RG | 1 |
| Björkholm, MJ; Engervall, PA; Günther, GC; Stiernstedt, GT | 1 |
| Bialkowska-Hobrzanska, H; Gopaul, D; Hammerberg, O | 1 |
| Bagot, M; Brun-Buisson, C; Chosidow, O; Fraitag, S; Girard-Pipau, F; Revuz, J; Roujeau, JC; Wolkenstein, P | 1 |
| Gedikoğlu, S; Göral, G; Helvaci, S; Kiliçturgay, K | 1 |
| Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP | 1 |
| Rong, XZ | 1 |
| Binder, L; Breitfellner, G; Mittermayer, H; Riezinger, F; Rotter, M; Thiel, W; Watschinger, R | 1 |
| Bazin, C; Deboscker, Y; Fourrier, F; Moulront, S; Mouton, Y; Philippon, A; Socolovsky, C; Suinat, JL; Tondriaux, A | 1 |
| Amadori, S; Martino, P; Micozzi, A; Pulsoni, A; Tirindelli, C; Venditti, M | 1 |
| Aversa, F; Bucaneve, G; Del Favero, A; Fiorio, M; Menichetti, F | 1 |
| Aoun, M; Bron, D; Meunier, F; Van der Auwera, P | 1 |
| Howell, AW; Jorgensen, JH; Longfield, RN; Smith, CE; Tillman, BS | 1 |
| Emanuelsson, BM; Isaksson, B; Maller, R; Nilsson, L | 1 |
| De Pauw, B; Donnelly, P; Nováková, I | 1 |
| Adland-Davenport, P; Brown, MP; Derendorf, HC; Robinson, JD | 1 |
| Al-Shab, T; Lubani, MM; Sethi, S; Sharda, DC | 1 |
| Hammerberg, O; Kurnitzki, C; Rosenbloom, D; Watts, J | 1 |
| Albanese, J; Brunel, MF; Durbec, O; Granthil, C; Soula, F | 1 |
| Baker, CJ; Kaplan, SL; Mason, EO; Parisi, JT; Patrick, CC | 1 |
| Beuscart, C; Drugeon, H; Leroy, O; Mouton, Y; Pappo, M | 1 |
| Inderlied, CB; Kolonoski, PT; Wu, M; Young, LS | 1 |
| Calandra, T; Gaya, H; Glauser, MP; Klastersky, J; Meunier, F; Zinner, SH | 1 |
| Aversa, F; Baldelli, F; Bucaneve, G; Davis, S; Del Favero, A; Guerciolini, R; Menichetti, F; Pauluzzi, S; Terenzi, A | 1 |
| Aversa, F; Baldelli, F; Bucaneve, G; Del Favero, A; Felicini, R; Menichetti, F; Pauluzzi, S; Terenzi, A | 1 |
| Munro, R; Rawlinson, W; Sorrell, T | 1 |
| McCracken, GH; Odio, CM; Saenz, A; Salas, JL; Umana, MA | 1 |
| Mylotte, JM | 1 |
| Auboyer, C; Becq-Giraudon, B; Bertrand, P; Buré, A; Carbon, C; Gallais, H; Motin, JP; Mouton, Y; Vachon, F; Wasmer, JM | 1 |
| Croydon, E; Weerts, D | 1 |
| Claveau, S; Joly, JR; Lapointe, R; Poirier, A | 1 |
| Alexopoulos, E; Anassis, P; Hadjidimitriou, C; Papadimitriou, M | 1 |
| Gaya, H; Glauser, MP; Klastersky, J; Schimpff, SC; Zinner, SH | 1 |
| Bonetti, A; Luthy, R; Siegenthaler, WE | 1 |
| Chadwick, EG; Shulman, ST; Yogev, R | 1 |
| Johnson, DE; Thompson, B | 1 |
| Klastersky, J; Lagast, H; Meunier, F; Snoeck, R; Woussen, F | 1 |
| Bru, JP; Hollard, D; Leautet, JB; Legrand, C; Michallet, M; Micoud, M; Sotto, JJ; Stahl, JP; Swierz, P | 1 |
| Arredondo-García, JL; Calderón-Jaimes, E; Conde-González, C; Echániz-Avilés, G; Reyes-Bolio, JM; Solórzano-Santos, F | 1 |
| Baird, B; Fauci, AS; Gill, V; Grimes, G; Lane, HC; Masur, H; Tuazon, C | 1 |
| Bouanchaud, DH; Rolin, O | 1 |
| Polis, MA; Tuazon, CU | 1 |
| Cafferkey, MT; Hone, R; Keane, CT | 1 |
| Mandelli, F; Martino, P; Serra, P; Valente, B; Venditti, M | 1 |
| Calia, FM; Johnson, DE; Thompson, B | 1 |
| Carson, CC; Paulson, DF; Rudd, C | 1 |
| Maslow, MJ; Rahal, JJ; Simberkoff, MS | 1 |
| Du, JZ; Jiang, YF; Liu, YH; Luo, MY; Qiu, ZD; Sheng, JQ; Wang, QN | 1 |
| Barton, LL; Fong, CT; Lustig, RH; Walentik, CA | 1 |
| Lee, CH; Lee, N; Tsai, WC; Wu, JL | 1 |
| Asada, H; Ito, A; Maruta, I; Matsuzaki, M; Ogawa, K | 1 |
| Artigas, A; Brunelli, L; Ferrer, R; Goma, G; Navas, A; Pastorelli, R; Ribas Ripoll, V; Romay, E | 1 |
2 review(s) available for amikacin and Blood Poisoning
| Article | Year |
|---|---|
Neonatal osteofibrous dysplasia associated with pathological tibia fracture: a case report and review of the literature.
Topics: Amikacin; Anti-Bacterial Agents; Casts, Surgical; Cefotaxime; Clindamycin; Fibrous Dysplasia of Bone; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Sepsis; Tibia; Tibial Fractures; Treatment Outcome | 2012 |
Aminoglycoside antibiotics in infectious diseases. An overview.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Kanamycin; Kinetics; Neomycin; Netilmicin; Pneumonia; Sepsis; Sisomicin; Streptomycin; Tobramycin | 1986 |
51 trial(s) available for amikacin and Blood Poisoning
| Article | Year |
|---|---|
Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Emergency Service, Hospital; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Prospective Studies; Sepsis; Shock, Septic; Tissue Distribution | 2021 |
Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; APACHE; Creatinine; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Female; Gram-Negative Bacterial Infections; Hemodynamics; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Sepsis; Severity of Illness Index; Tissue Distribution | 2013 |
Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, Liquid; Ear Diseases; Female; Gentamicins; Hearing; Hearing Tests; Humans; Indonesia; Infant; Infant, Newborn; Male; Otoacoustic Emissions, Spontaneous; Risk Factors; Sepsis; Tandem Mass Spectrometry | 2013 |
Comparison of two empiric antibiotic regimen in late onset neonatal sepsis--a randomized controlled trial.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cloxacillin; Drug Therapy, Combination; Female; Follow-Up Studies; Gentamicins; Hospitals, Teaching; Humans; India; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Length of Stay; Male; Outcome Assessment, Health Care; Sepsis; Single-Blind Method; Time Factors | 2014 |
Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; India; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Sepsis; Treatment Outcome | 2014 |
[In the search for effective and safe dose of amikacin in patients with chronic kidney disease].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Insufficiency, Chronic; Sepsis; Treatment Outcome; Urinary Tract Infections; Urine | 2014 |
Role of prophylactic antibiotics in neonates born through meconium-stained amniotic fluid (MSAF)--a randomized controlled trial.
Topics: Amikacin; Amniotic Fluid; Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Female; Humans; Infant, Newborn; Infusions, Intravenous; Male; Meconium; Meconium Aspiration Syndrome; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pregnancy; Prospective Studies; Sepsis | 2015 |
Administration of higher doses of amikacin in early stages of sepsis in critically ill patients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Sepsis; Single-Blind Method | 2014 |
The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
Topics: Acetylglucosaminidase; Amikacin; Anti-Bacterial Agents; Creatinine; Drug Administration Schedule; Female; Half-Life; Humans; Infant, Newborn; Male; Metabolic Clearance Rate; Renal Insufficiency; Sepsis | 2011 |
Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Creatinine; Female; Humans; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Plasma; Sepsis | 2011 |
Is ceftizoxime an appropriate surrogate for amikacin in neonatal sepsis treatment? A randomized clinical trial.
Topics: Amikacin; Anti-Bacterial Agents; Ceftizoxime; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Sepsis | 2011 |
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Critical Illness; Drug Monitoring; Female; Humans; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Models, Biological; Piperacillin; Sepsis; Thienamycins; Tissue Distribution; Treatment Outcome | 2012 |
Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endosonography; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Prostate; Rectum; Sepsis; Treatment Outcome | 2013 |
Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Ceftriaxone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Peritonitis; Recombinant Proteins; Sepsis; Survival Rate; Treatment Outcome | 2006 |
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
Efficacy and renal toxicity of one daily dose of amikacin versus conventional dosage regime.
Topics: Amikacin; Anti-Bacterial Agents; beta 2-Microglobulin; Creatine; Double-Blind Method; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidney; Sepsis | 2007 |
Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Sepsis; Time Factors | 2007 |
Early granulocyte transfusions in high risk febrile neutropenic patients.
Topics: Agranulocytosis; Amikacin; Blood Transfusion; Carbenicillin; Clinical Trials as Topic; Gram-Negative Bacteria; Granulocytes; Humans; Neutropenia; Risk; Sepsis | 1983 |
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Pseudomonas Infections; Sepsis; Staphylococcal Infections | 1984 |
Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.
Topics: Amikacin; Body Temperature; Female; Gentamicins; Hearing Loss; Humans; Kanamycin; Male; Probability; Risk; Sepsis; Statistics as Topic; Time Factors; Tobramycin | 1984 |
Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Gentamicins; Humans; Kanamycin; Lung Diseases; Male; Middle Aged; Netilmicin; Sepsis; Urinary Tract Infections | 1980 |
Aminoglycosides in the treatment of bacteraemic infections in the immuno-comprised host.
Topics: Agranulocytosis; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Therapy, Combination; Gentamicins; Humans; Netilmicin; Neutropenia; Sepsis | 1981 |
Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone.
Topics: Adolescent; Adult; Aged; Amikacin; Ceftriaxone; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neutropenia; Sepsis | 1993 |
Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbapenems; Ceftazidime; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Respiratory Tract Infections; Sepsis; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections | 1995 |
Safety and efficacy of meropenem in patients with septicaemia: a randomised comparison with ceftazidime, alone or combined with amikacin.
Topics: Adult; Aged; Amikacin; Carbapenems; Ceftazidime; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Sepsis; Thienamycins; Treatment Outcome | 1995 |
Amikacin Bayesian forecasting in critically ill patients with sepsis and cirrhosis.
Topics: Amikacin; Anti-Bacterial Agents; Bayes Theorem; Critical Illness; Humans; Liver Cirrhosis; Middle Aged; Sepsis | 1997 |
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Bacterial; Sepsis | 2000 |
Controlled comparison of amikacin and gentamicin.
Topics: Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Clinical Trials as Topic; Drug Evaluation; Drug Resistance, Microbial; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney; Middle Aged; Prospective Studies; Sepsis; Urinary Tract Infections | 1977 |
Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Gentamicins; Humans; Infections; Kanamycin; Male; Middle Aged; Neoplasms; Penicillin Resistance; Penicillins; Sepsis; Ticarcillin | 1979 |
Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Female; Humans; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Neoplasms; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tobramycin; Urinary Tract Infections | 1977 |
Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.
Topics: Adult; Amikacin; Bacterial Infections; Carbenicillin; Drug Synergism; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Leukopenia; Penicillin Resistance; Sepsis | 1977 |
Evaluation of three antibiotic programs in newborn infants.
Topics: Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bilirubin; Cephalothin; Drug Therapy, Combination; Evaluation Studies as Topic; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pneumonia; Sepsis; Tobramycin | 1978 |
Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial.
Topics: Amikacin; Bacterial Infections; Blood Bactericidal Activity; Carbenicillin; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Kanamycin; Penicillin G; Pseudomonas Infections; Sepsis | 1976 |
A review of results of clinical trials with amikacin.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Bone Diseases; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Kanamycin; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1976 |
Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Pneumocystis Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer In
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Gram-Positive Bacteria; Humans; Infant; Male; Middle Aged; Neoplasms; Prospective Studies; Sepsis; Vancomycin | 1991 |
[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sepsis | 1990 |
Gram-positive bacteraemia in granulocytopenic cancer patients.
Topics: Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Sepsis | 1990 |
Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Sepsis; Teicoplanin | 1990 |
Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever; Glycopeptides; Humans; Leukemia; Male; Middle Aged; Neoplasms; Prospective Studies; Sepsis; Teicoplanin | 1990 |
Amikacin once daily: a new dosing regimen based on drug pharmacokinetics.
Topics: Aged; Amikacin; Creatinine; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Sepsis | 1990 |
Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.
Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Aspergillosis; Aspergillus fumigatus; Ceftazidime; Cell Count; Drug Therapy, Combination; Female; Fever; Humans; Male; Piperacillin; Sepsis | 1990 |
Randomized trial using piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis.
Topics: Amikacin; Ampicillin; Bacterial Infections; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Infant, Premature, Diseases; Piperacillin; Random Allocation; Risk Factors; Sepsis | 1989 |
[Prospective randomized controlled study of a ceftazidime and pefloxacin combination versus a ceftazidime and amikacin combination in the empirical treatment of pneumonia and nosocomial septicemia at intensive care units].
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Multicenter Studies as Topic; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation; Sepsis | 1989 |
Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Ceftazidime; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Neoplasms; Prognosis; Random Allocation; Regression Analysis; Sepsis | 1987 |
Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
Topics: Acute Disease; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacteria; Humans; Leukemia; Prospective Studies; Random Allocation; Sepsis; Teicoplanin | 1987 |
Cefotaxime (C) vs cefotaxime + amikacin (C + A) in the treatment of septicemia due to enterobacteria: a multicenter study.
Topics: Amikacin; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Sepsis | 1987 |
European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
Topics: Adult; Agranulocytosis; Amikacin; Bacterial Infections; beta-Lactamase Inhibitors; Child; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Netilmicin; Neutropenia; Penicillins; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1987 |
Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Cefotaxime; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Male; Middle Aged; Penicillins; Prospective Studies; Random Allocation; Regression Analysis; Sepsis; Ticarcillin | 1986 |
A prospective randomized study comparing the efficacy of Timentin alone or in combination with amikacin in the treatment of febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Clavulanic Acids; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Male; Middle Aged; Penicillin Resistance; Penicillins; Prospective Studies; Random Allocation; Sepsis; Ticarcillin | 1986 |
Laboratory and clinical studies on amikacin.
Topics: Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Kanamycin; Pyelonephritis; Sepsis; Staphylococcus aureus | 1985 |
151 other study(ies) available for amikacin and Blood Poisoning
| Article | Year |
|---|---|
Relationship between amikacin pharmacokinetics and biological parameters associated with organ dysfunction: a case series study of critically ill patients with intra-abdominal sepsis.
Topics: Amikacin; Anti-Bacterial Agents; Critical Illness; Humans; Multiple Organ Failure; Sepsis | 2022 |
Congenital brucellosis associated with subsequent Klebsiella pneumoniae co-infection in a premature neonate: A rare case report.
Topics: Amikacin; Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Coinfection; Female; Gentamicins; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Respiratory Distress Syndrome; Rifampin; Sepsis | 2022 |
Amikacin Monotherapy for Peripherally Inserted Central Catheter-Related Bloodstream Infection due to Tsukamurella pulmonis.
Topics: Actinobacteria; Amikacin; Catheter-Related Infections; Catheterization, Central Venous; Catheterization, Peripheral; Catheters; Humans; Risk Factors; Sepsis | 2022 |
Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Female; Formaldehyde; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis | 2022 |
Aetiology, antimicrobial susceptibility and outcome of children with sepsis, admitted at Muhimbili National Hospital, Dar es Salaam.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Clindamycin; Coagulase; Cross-Sectional Studies; Escherichia coli; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Infant; Male; Meropenem; Microbial Sensitivity Tests; Prospective Studies; Sepsis; Staphylococcus aureus; Tanzania | 2022 |
In vitro antibacterial activity and in vivo pharmacokinetics of intravenously administered Amikacin-loaded Liposomes for the management of bacterial septicaemia.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Liposomes; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley; Sepsis; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Analysis of drug resistance genes of integrons in clinical isolates of Escherichia coli from elderly bloodstream infections.
Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefoxitin; Clavulanic Acid; Drug Resistance; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Integrons; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Sepsis; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Whole genome sequencing of OXA-232-producing
Topics: Amikacin; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromosomes; Ciprofloxacin; DNA Transposable Elements; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis; Virulence; Virulence Factors; Whole Genome Sequencing | 2022 |
Amikacin-induced acute kidney injury in mechanically ventilated critically ill patients with sepsis.
Topics: Acute Kidney Injury; Amikacin; Colistin; Critical Illness; Humans; Intensive Care Units; Respiration, Artificial; Retrospective Studies; Risk Factors; Sepsis; Shock, Septic | 2023 |
A 12-Year Retrospective Analysis of Blood Culture Isolates in the Intensive Care Unit of a Tertiary Hospital in China.
Topics: Amikacin; Anti-Bacterial Agents; Blood Culture; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Intensive Care Units; Linezolid; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Sepsis; Teicoplanin; Tertiary Care Centers; Vancomycin | 2023 |
Population pharmacokinetics of amikacin in suspected cases of neonatal sepsis.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Infant, Newborn; Metabolic Clearance Rate; Neonatal Sepsis; Sepsis | 2023 |
Therapeutic drug monitoring of amikacin in preterm and term neonates with late-onset sepsis. Can saliva samples replace plasma samples?
Topics: Amikacin; Anti-Bacterial Agents; Drug Monitoring; Female; Humans; Infant, Newborn; Premature Birth; Prospective Studies; Saliva; Sepsis | 2023 |
Evaluation of Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Glomerular Filtration Rate and Amikacin Clearance During Early Rat Endotoxemia: Comparison with Traditional Endogenous and Exogenous Biomarkers.
Topics: Acute Kidney Injury; Amikacin; Animals; Biomarkers; Cytokines; Endotoxemia; Glomerular Filtration Rate; Inflammation; Kidney; Lipocalin-2; Lipopolysaccharides; Male; Metabolic Clearance Rate; Models, Animal; Oligosaccharides; Predictive Value of Tests; Rats; Rats, Wistar; Sepsis; Urine | 2020 |
Amikacin Pharmacokinetics To Optimize Dosing in Neonates with Perinatal Asphyxia Treated with Hypothermia.
Topics: Amikacin; Anti-Bacterial Agents; Asphyxia; Drug Administration Schedule; Drug Monitoring; Female; Humans; Hypothermia, Induced; Infant, Newborn; Monte Carlo Method; Obstetric Labor Complications; Parturition; Pregnancy; Sepsis | 2017 |
Optimal Amikacin Levels for Patients with Sepsis in Intensive Care Unit of Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cross-Sectional Studies; Dose-Response Relationship, Drug; Escherichia coli; Female; Humans; Indonesia; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Sepsis; Young Adult | 2017 |
[Antimicrobial susceptibility of bacteria causing urosepsis].
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Blood Culture; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis; Ureterolithiasis; Urinary Tract Infections; Young Adult | 2017 |
Myocardial calcifications following sepsis.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Calcinosis; Cardiomyopathies; Cefotaxime; Female; Humans; Norepinephrine; Sepsis; Treatment Outcome; Vasoconstrictor Agents | 2018 |
Initial antimicrobial treatment of foals with sepsis: Do our choices make a difference?
Topics: Amikacin; Ampicillin; Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Horse Diseases; Horses; Retrospective Studies; Sepsis | 2019 |
PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin, Imipenem Drug Combination; Coronary Care Units; Drug Monitoring; Extracorporeal Membrane Oxygenation; Female; Gentamicins; Humans; Male; Middle Aged; Pilot Projects; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Tobramycin | 2019 |
Nocardial endocarditis in native aortic valve with nocardial sepsis in a case of breast cancer.
Topics: Amikacin; Anti-Bacterial Agents; Anticoagulants; Aortic Valve; Breast Neoplasms; Central Venous Catheters; Clopidogrel; Cough; Endocarditis, Bacterial; Fatigue; Female; Headache; Heart Valve Prosthesis Implantation; Humans; Meropenem; Middle Aged; Nocardia; Nocardia Infections; Platelet Aggregation Inhibitors; Radiography, Thoracic; Sepsis; Treatment Outcome; Warfarin | 2019 |
Re: Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate: E. O. Kehinde, M. Al-maghrebi, M. Sheikh and J. T. Anim J Urol 2013, 189: 911-915.
Topics: Amikacin; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Endosonography; Humans; Male; Prostate; Sepsis | 2013 |
Amikacin population pharmacokinetics among paediatric burn patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Body Surface Area; Body Weight; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Multivariate Analysis; Regression Analysis; Sepsis; Vancomycin | 2014 |
Therapeutic drug monitoring of amikacin in septic patients.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Sepsis | 2013 |
Reply by authors.
Topics: Amikacin; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Endosonography; Humans; Male; Prostate; Sepsis | 2013 |
Aminoglycosides and ototoxicity in neonates: is there a relation with serum concentrations?
Topics: Amikacin; Anti-Bacterial Agents; Ear Diseases; Female; Gentamicins; Hearing; Humans; Male; Sepsis | 2013 |
Reply by authors.
Topics: Amikacin; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Endosonography; Humans; Male; Prostate; Sepsis | 2014 |
Re: combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate: O. Kehinde, M. Al-Maghrebi, M. Sheikh and J. T. Anim J Urol 2013; 189: 911–915.
Topics: Amikacin; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Endosonography; Humans; Male; Prostate; Sepsis | 2014 |
Cerebral abscess due to Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Drainage; Frontal Lobe; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Long Term Adverse Effects; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Serratia marcescens; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline | 2015 |
Even high-dose extended infusions may not yield desired concentrations of β-lactams: the value of therapeutic drug monitoring.
Topics: Adult; Amikacin; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Bacterial; Female; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Thienamycins | 2015 |
Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
Topics: Amikacin; Anti-Bacterial Agents; Birth Weight; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Male; Models, Statistical; Monte Carlo Method; Precision Medicine; Prospective Studies; Sepsis | 2015 |
Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Critical Illness; Female; France; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis; Serum; Young Adult | 2016 |
Neonatal Conjunctivitis Leading to Neonatal Sepsis--A Case Report.
Topics: Amikacin; Anti-Bacterial Agents; Conjunctivitis; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Male; Meropenem; Sepsis; Thienamycins; Treatment Outcome | 2016 |
Netilmicin withdrawal: impact on neonates.
Topics: Amikacin; Anti-Bacterial Agents; Drug and Narcotic Control; Humans; Infant, Newborn; Medical Audit; Netilmicin; New Zealand; Retrospective Studies; Sepsis; Staphylococcal Infections; Streptococcal Infections; Streptococcus agalactiae; Treatment Failure | 2008 |
[Case of sepsis caused by multidrug-resistant neutropenic-phase Pseudomonas aeruginosa treated successfully with antibiotic combination therapy].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Treatment Outcome | 2008 |
Inadequate timing between corticosteroid and antibiotics applications increases mortality due to sepsis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Administration Schedule; Escherichia coli Infections; Glucocorticoids; Klebsiella Infections; Male; Methylprednisolone; Mice; Sepsis; Staphylococcal Infections; Teicoplanin | 2008 |
Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.
Topics: Amikacin; Anti-Bacterial Agents; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Menstruation; Metabolic Clearance Rate; Models, Biological; Reproducibility of Results; Risk Factors; Sepsis; Time Factors; Treatment Failure | 2009 |
[Cost of therapeutic failure of ampicillin plus amikacin in the treatment of early neonatal sepsis].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Costs and Cost Analysis; Decision Trees; Drug Therapy, Combination; Humans; Infant, Newborn; Sepsis; Time Factors; Treatment Failure | 2009 |
Therapeutic drug monitoring of amikacin in preterm and term infants.
Topics: Age Factors; Amikacin; Anti-Bacterial Agents; Drug Monitoring; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Risk Factors; Sepsis | 2009 |
Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Calibration; Critical Illness; Drug Dosage Calculations; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Empirical Research; Female; Humans; Male; Middle Aged; Models, Theoretical; Sepsis; Young Adult | 2010 |
Amikacin monotherapy for sepsis caused by panresistant Pseudomonas aeruginosa.
Topics: Aged; Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Creatinine; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Sepsis | 2010 |
Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bayes Theorem; Creatinine; Critical Illness; Drug Monitoring; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Sepsis; Tissue Distribution | 2010 |
Optimising amikacin regimens in septic patients.
Topics: Amikacin; Anti-Bacterial Agents; Female; Humans; Male; Plasma; Sepsis | 2012 |
[Neonatal infection with Stenotrophomonas maltophilia (2 case studies)].
Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Chloramphenicol; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Echoencephalography; Empyema, Subdural; Fatal Outcome; Female; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Pneumonia, Bacterial; Sepsis; Stenotrophomonas maltophilia; Thiamphenicol; Tomography, X-Ray Computed | 2012 |
Facial ecthyma gangrenosum in 2 preterm neonates.
Topics: Amikacin; Facial Dermatoses; Fatal Outcome; Female; Gangrene; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Meropenem; Necrosis; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Skin Diseases, Bacterial; Skin Ulcer; Thienamycins | 2012 |
Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome.
Topics: Amikacin; Ampicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cloxacillin; Escherichia coli; Female; Gentamicins; Humans; Infant, Newborn; Klebsiella; Male; Microbial Sensitivity Tests; Sepsis; Staphylococcus aureus; Tanzania; Treatment Outcome | 2012 |
Aminoglycoside and vancomycin serum concentration monitoring and mortality due to neonatal sepsis in Saudi Arabia.
Topics: Amikacin; Anti-Bacterial Agents; Gentamicins; Humans; Incidence; Infant, Newborn; Retrospective Studies; Saudi Arabia; Sepsis; Vancomycin | 2003 |
Neonatal sepsis and meningitis in Haiti.
Topics: Amikacin; Anti-Bacterial Agents; Enterobacter aerogenes; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Haiti; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Prospective Studies; Sepsis | 2004 |
Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Neutropenia; Opportunistic Infections; Risk Assessment; Sepsis | 2004 |
n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.
Topics: alpha-Linolenic Acid; Amikacin; Animals; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporins; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fatty Acids, Unsaturated; Lipopolysaccharides; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sepsis; Tumor Necrosis Factor-alpha | 2004 |
Chromobacterium violaceum septicaemia from north India.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Chromobacterium; Ciprofloxacin; Female; Humans; India; Infant; Infant, Newborn; Male; Sepsis | 2004 |
Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Inflammation; Lipopolysaccharides; Malondialdehyde; Pyelonephritis; Rabbits; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
[Azlocillin plus amikacin: an alternative therapy for sepsis caused by resistant staphylococci?].
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Models, Theoretical; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus | 2004 |
Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Caspase 3; Caspases; Clarithromycin; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Immunologic Factors; Male; Malondialdehyde; Pulmonary Edema; Pyelonephritis; Rabbits; Sepsis; Tumor Necrosis Factor-alpha | 2005 |
Antibiotic-induced release of inflammatory mediators from bacteria in experimental Klebsiella pneumoniae-induced sepsis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Disease Models, Animal; Endotoxins; Humans; Inflammation; Klebsiella Infections; Klebsiella pneumoniae; Mice; Ofloxacin; Sepsis; Tumor Necrosis Factor-alpha | 2005 |
The use of piperacillin/tazobactam (in association with amikacin) in neonatal sepsis: efficacy and safety data.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis | 2006 |
Neonatal diarrhea and septicemia in an American Miniature Horse.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Blood Cell Count; Blood Chemical Analysis; Dehydration; Diarrhea; Fluid Therapy; Glucose; Horse Diseases; Horses; Hyperemia; Infusions, Intravenous; Male; Penicillins; Sepsis; Sodium Chloride; Sweetening Agents; Urinalysis | 2006 |
Oleuropein: a novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Cells, Cultured; Humans; Immunologic Factors; Iridoid Glucosides; Iridoids; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrans; Rabbits; Sepsis; Survival | 2006 |
Chromobacterium violaceum: a case report of an unusual bacterium causing puerperal sepsis.
Topics: Academic Medical Centers; Adult; Amikacin; Anti-Bacterial Agents; Chromobacterium; Female; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; India; Puerperal Infection; Sepsis | 2006 |
Paratyphoid sepsis.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bottle Feeding; Breast Feeding; Cesarean Section; Female; Follow-Up Studies; Humans; India; Infusions, Intravenous; Male; Ofloxacin; Paratyphoid Fever; Pregnancy; Risk Assessment; Salmonella paratyphi A; Sepsis; Treatment Outcome | 2007 |
Are we finally ready for outpatient management of febrile neutropenia?
Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Monitoring, Physiologic; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Safety Management; Sepsis; Time Factors | 2007 |
[Sepsis caused by pigmented and no pigmented Chromobacterium violaceum].
Topics: Amikacin; Anti-Bacterial Agents; Chromobacterium; Fatal Outcome; Gram-Negative Bacterial Infections; Humans; Imipenem; Indians, South American; Infant; Male; Psoas Abscess; Sepsis | 2007 |
Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cost-Benefit Analysis; Croatia; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Longitudinal Studies; Netilmicin; Prospective Studies; Sepsis | 2008 |
[The determination of pharmacokinetic parameters from surveillance protocols of sepsis therapy].
Topics: Amikacin; Cefoxitin; Computers; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Metabolic Clearance Rate; Penicillin G; Sepsis | 1983 |
Aminoglycoside-related nephrotoxicity in the premature newborn.
Topics: Acetylglucosaminidase; Amikacin; beta 2-Microglobulin; Chloramphenicol; Creatinine; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Kanamycin; Kidney Diseases; Prospective Studies; Random Allocation; Sepsis | 1984 |
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin | 1980 |
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.
Topics: Adult; Aged; Amikacin; Body Temperature; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Kidney Diseases; Leukocyte Count; Middle Aged; Proteus Infections; Sepsis; Statistics as Topic; Tobramycin | 1984 |
Etiology of infections in neutropenic patients with acute leukemia. Results of two antibiotic combinations.
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cephalothin; Cephapirin; Child; Child, Preschool; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia; Random Allocation; Sepsis; Tobramycin | 1981 |
Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Sepsis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
Fatal pneumonia. Emergence of an amikacin sulfate-resistant strain of Escherichia coli.
Topics: Amikacin; Drug Resistance, Microbial; Escherichia coli; Humans; Kanamycin; Male; Middle Aged; Pneumonia; Sepsis | 1981 |
Amikacin treatment of Serratia septicemia in critically ill patients.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Critical Care; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Sepsis; Serratia marcescens | 1981 |
Therapy of Klebsiella pneumoniae septicaemia in neutropenic rats.
Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Female; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Rats; Rats, Inbred Strains; Sepsis; Sisomicin; Tobramycin | 1982 |
[Clinical report of an aged patient with lung abscess who show an excellent response after long-term administration of amikacin (author's transl)].
Topics: Aged; Amikacin; Bacteria; Drug Resistance, Microbial; Female; Humans; Kanamycin; Lung Abscess; Sepsis | 1982 |
Bacteremic group G streptococcal pneumonia.
Topics: Amikacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Penicillin G Procaine; Pneumonia; Sepsis; Streptococcal Infections; Streptococcus | 1982 |
Mycobacterium chelonei septicemia in a premature infant.
Topics: Amikacin; Erythromycin; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis | 1980 |
Guidelines for adequate chemotherapeutic dosage in newborns and infants with septicaemia and meningitis.
Topics: Amikacin; Anti-Bacterial Agents; Cefuroxime; Colistin; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Meningitis; Sepsis; Tobramycin | 1980 |
Evaluation of amikacin dosage regimes in the low and very low birthweight newborn.
Topics: Amikacin; Dose-Response Relationship, Drug; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Male; Sepsis | 1980 |
[Is it possible to save an infected catheter?].
Topics: Adult; Amikacin; Anesthesia; Catheterization, Central Venous; Catheters, Indwelling; Drug Resistance, Microbial; Equipment Contamination; Fatal Outcome; Female; Heparin; Humans; Jugular Veins; Pseudomonas; Pseudomonas Infections; Renal Dialysis; Seizures; Sepsis | 1994 |
Aminoglycoside volume of distribution and illness severity in critically ill septic patients.
Topics: Adult; Amikacin; Creatinine; Critical Illness; Extracellular Space; Gram-Negative Bacterial Infections; Humans; Sepsis; Severity of Illness Index | 1993 |
Volume distribution of amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Computer Simulation; Humans; Kidney; Metabolic Clearance Rate; Models, Biological; Sepsis; Tissue Distribution | 1997 |
Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.
Topics: Adult; Amikacin; Anti-Bacterial Agents; APACHE; Critical Care; Cross-Sectional Studies; Female; Gram-Negative Bacterial Infections; Half-Life; Hemodynamics; Humans; Infusion Pumps; Intensive Care Units; Male; Metabolic Clearance Rate; Middle Aged; Sepsis | 1997 |
Bayesian approach to control of amikacin serum concentrations in critically ill patients with sepsis.
Topics: Amikacin; Anti-Bacterial Agents; Bayes Theorem; Critical Care; Critical Illness; Humans; Middle Aged; Models, Statistical; Retrospective Studies; Sepsis | 2000 |
Aeromonas sobria sepsis in a neutropenic patient.
Topics: Acute Disease; Aeromonas; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid; Neutropenia; Sepsis | 2001 |
Renal elimination of amikacin and the aging process.
Topics: Adult; Aged; Aged, 80 and over; Aging; Amikacin; Anti-Bacterial Agents; France; Humans; Kidney; Metabolic Clearance Rate; Middle Aged; Multicenter Studies as Topic; Probability; Retrospective Studies; Sepsis | 2001 |
[Nosocomial catheter-related sepsis secondary to central venous catheters].
Topics: Amikacin; Anti-Bacterial Agents; Catheterization, Central Venous; Cross Infection; Drug Resistance, Microbial; Female; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1999 |
Antibiotic susceptibility pattern of Salmonella worthington isolated from neonates--a retrospective study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Norfloxacin; Penicillins; Prevalence; Retrospective Studies; Salmonella; Salmonella Infections; Sepsis; Time Factors | 2002 |
[Septicaemia in leukaemia (author's transl)].
Topics: Adult; Amikacin; Ampicillin; Chloramphenicol; Female; Gentamicins; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Leukemia; Leukemia, Lymphoid; Mycoses; Sepsis; Staphylococcal Infections; Streptococcal Infections | 1977 |
[Intravenous administration of amikacin sulfate for the infections complicated with hematologic disorders (author's transl)].
Topics: Adolescent; Adult; Amikacin; Anemia, Aplastic; Female; Hematologic Diseases; Humans; Infections; Injections, Intravenous; Kanamycin; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia; Sepsis | 1977 |
Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Ear; Gentamicins; Humans; Kanamycin; Middle Aged; Pseudomonas; Sepsis; Serratia marcescens; Tobramycin | 1977 |
Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
Topics: Adolescent; Adult; Aged; Amikacin; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Kanamycin; Klebsiella Infections; Meningitis; Proteus Infections; Sepsis; Serratia marcescens | 1978 |
Antimicrobial therapy of septicemia due to Klebsiella pneumoniae in neutropenic rats.
Topics: Agranulocytosis; Amikacin; Animals; Cefazolin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neutropenia; Rats; Sepsis | 1979 |
Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; In Vitro Techniques; Infant; Kanamycin; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Serratia marcescens; Urinary Tract Infections | 1978 |
Clinical evaluation of netilmicin therapy in serious infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Netilmicin; Sepsis; Urinary Tract Infections | 1979 |
[Clinical and pharmacokinetic study of amikacin in septicemia complicating major burns].
Topics: Adolescent; Adult; Aged; Amikacin; Burns; Humans; Kanamycin; Kinetics; Microbial Sensitivity Tests; Middle Aged; Sepsis | 1979 |
[Amikacin in the treatment of Gram negative bacilli septicemias].
Topics: Amikacin; Critical Care; Enterobacteriaceae; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Sepsis; Tobramycin | 1979 |
Amikacin therapy for serious gram-negative infection.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Kanamycin; Kidney; Klebsiella Infections; Middle Aged; Pseudomonas Infections; Sepsis | 1977 |
Proteus rettgeri infections: a review.
Topics: Adolescent; Amikacin; Gentamicins; Humans; Male; Penicillin Resistance; Penicillins; Proteus Infections; Quadriplegia; Sepsis | 1977 |
Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
Topics: Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Bacterial Infections; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1976 |
Use of Amikacin in a hospital for children: microbiological and clinical studies.
Topics: Amikacin; Aminoglycosides; Bacterial Infections; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Kanamycin; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1976 |
Nosocomial bloodstream infections caused by gentamicin-resistant gram-negative bacilli.
Topics: Adult; Aged; Amikacin; Cross Infection; Drug Resistance, Microbial; Female; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 1977 |
Amikacin therapy for gram-negative septicemia.
Topics: Adult; Aged; Amikacin; Creatinine; Drug Resistance, Microbial; Female; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Sepsis | 1977 |
Amikacin therapy of gram-negative bacteremia.
Topics: Amikacin; Gentamicins; Hearing Disorders; Humans; Kanamycin; Sepsis | 1977 |
Review of 152 patients with bacteremias treated with amikacin.
Topics: Adult; Aged; Amikacin; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Middle Aged; Sepsis | 1977 |
Gram-negative sepsis: part II. Management.
Topics: Acidosis; Adult; Amikacin; Child; Chloramphenicol; Clindamycin; Disseminated Intravascular Coagulation; Dopamine; Gentamicins; Heart Failure; Humans; Isoproterenol; Kanamycin; Kidney Diseases; Metaraminol; Phenoxybenzamine; Respiratory Insufficiency; Sepsis; Tobramycin | 1977 |
[Therapeutic experience of Proteus morganii septicemia with amikacin (author's transl)].
Topics: Amikacin; Humans; Intracranial Aneurysm; Kanamycin; Male; Middle Aged; Proteus Infections; Sepsis | 1977 |
Use of aminoglycosides in surgical infections.
Topics: Abscess; Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Female; Gentamicins; Humans; Infant; Male; Middle Aged; Peritonitis; Sepsis; Sisomicin; Surgical Wound Infection; Tobramycin; Wound Infection | 1976 |
Amikacin.
Topics: Amikacin; Bacteria; Drug Resistance, Microbial; Humans; Infant, Newborn; Kanamycin; Sepsis | 1976 |
Amikacin for treatment of septic abortions: summary.
Topics: Abortion, Septic; Amikacin; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Pregnancy; Sepsis | 1976 |
Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Chronic Disease; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Peritonitis; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1976 |
Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms.
Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections; Sepsis | 1976 |
[A case of E. coli septicemia successfully treated with amikacin (author's transl)].
Topics: Amikacin; Carbenicillin; Cefazolin; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Sepsis | 1975 |
[Contaminated infusions as cause of nosocomial Serratia marcescens septicaemia in children (author's transl)].
Topics: Age Factors; Amikacin; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Infusions, Parenteral; Nalidixic Acid; Sepsis; Serratia marcescens | 1975 |
Amikacin therapy for serious gram-negative bacillary infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Ear, Inner; Female; Humans; Kanamycin; Kidney; Male; Middle Aged; Osteomyelitis; Peritonitis; Pneumonia; Sepsis; Urinary Tract Infections | 1975 |
Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia.
Topics: Adult; Amikacin; Ceftazidime; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Mycoses; Neoplasms; Neutropenia; Saudi Arabia; Sepsis; Treatment Outcome | 1992 |
Isolation of Agrobacterium radiobacter from a central venous catheter.
Topics: Amikacin; Catheterization, Central Venous; Catheters, Indwelling; Equipment Contamination; Female; Humans; Leukemia, Monocytic, Acute; Middle Aged; Piperacillin; Rhizobium; Sepsis | 1991 |
Nocardia asteroides septicemia in a pemphigus patient. Successful treatment with trimethoprim-sulfamethoxazole and amikacin association.
Topics: Amikacin; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Middle Aged; Nocardia asteroides; Nocardia Infections; Pemphigus; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
[Salmonella typhimurium infections in the area of Bursa].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefotaxime; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Salmonella Infections; Salmonella typhimurium; Sepsis; Turkey | 1990 |
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin | 1990 |
[Experimental study of pulmonary infection and its systemic dissemination in the early stage of severe burn].
Topics: Amikacin; Animals; Burns; Disease Susceptibility; Endotoxins; Female; Male; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sepsis | 1990 |
Resistance of gram-negative bacilli and staphylococci from blood cultures to aminoglycoside antibiotics. Comparison of 3 in vitro investigations from Austria 1982-1988.
Topics: Amikacin; Anti-Bacterial Agents; Austria; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Humans; Netilmicin; Pseudomonas aeruginosa; Sepsis; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Tobramycin | 1990 |
Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteria; Bone Marrow Transplantation; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Leukemia; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Sepsis; Teicoplanin | 1990 |
Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
Topics: Adult; Amikacin; beta-Lactamases; Blotting, Southern; Ceftazidime; DNA, Bacterial; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Microbial Sensitivity Tests; Sepsis; Wounds and Injuries | 1990 |
Pharmacokinetics of amikacin in critically ill neonatal foals treated for presumed or confirmed sepsis.
Topics: Amikacin; Animals; Animals, Newborn; Horse Diseases; Horses; Immunization, Passive; Least-Squares Analysis; Pneumonia; Sepsis | 1990 |
Neonatal listeriosis: a report of seven cases.
Topics: Amikacin; Ampicillin; Cerebrospinal Fluid; Disease Outbreaks; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Kuwait; Listeriosis; Male; Meningitis, Listeria; Sepsis | 1987 |
[Fulminating Pseudomonas maltophilia septicemia during treatment with imipenem and amikacin].
Topics: Amikacin; Drug Resistance, Microbial; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Sepsis | 1989 |
Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates.
Topics: Amikacin; Bacteriophage Typing; Coagulase; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Male; Methicillin; Sepsis; Species Specificity; Staphylococcal Infections; Staphylococcus; Vancomycin | 1989 |
Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Female; Imipenem; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Organ Size; Sepsis | 1989 |
Teicoplanin in empirical combined antibiotic therapy of bacteraemias in bone marrow transplant patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ceftazidime; Child; Drug Therapy, Combination; Female; Glycopeptides; Humans; Male; Middle Aged; Postoperative Complications; Sepsis; Teicoplanin | 1988 |
Bacteremia in neutropenic patients at a major teaching hospital--1981 to 1987.
Topics: Agranulocytosis; Amikacin; Australia; Cefotaxime; Drug Therapy, Combination; Gentamicins; Hospitals, Teaching; Humans; Neutropenia; Piperacillin; Sepsis; Ticarcillin | 1988 |
Treatment of gram-negative bacteremia in patients with cancer and granulocytopenia.
Topics: Agranulocytosis; Amikacin; Ceftazidime; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Neoplasms; Sepsis | 1988 |
Comparative efficacy of ceftazidime vs. carbenicillin and amikacin for treatment of neonatal septicemia.
Topics: Amikacin; Bacteria; Blood Bactericidal Activity; Carbenicillin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Male; Penicillin Resistance; Recurrence; Sepsis | 1987 |
Gentamicin resistance among gram-negative bacillary blood isolates in a hospital with long-term use of gentamicin.
Topics: Amikacin; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Gentamicins; Humans; Klebsiella pneumoniae; Proteus mirabilis; Sepsis; Serratia marcescens | 1987 |
In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Bacteriuria; Drug Resistance, Microbial; Escherichia coli; Europe; Gentamicins; Humans; Netilmicin; Pseudomonas; Sepsis; Staphylococcus; Tobramycin | 1987 |
Bacteremia caused by Pseudomonas mesophilica.
Topics: Amikacin; Catheterization, Central Venous; Catheters, Indwelling; Humans; Male; Middle Aged; Pseudomonas Infections; Sepsis | 1988 |
The efficacy of amikacin in the treatment of severe infections in a renal unit.
Topics: Amikacin; Bacteria; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Hospital Units; Humans; Kidney Diseases; Male; Middle Aged; Penicillins; Sepsis | 1987 |
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
Topics: Agranulocytosis; Amikacin; Animals; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Imipenem; Kanamycin; Kinetics; Klebsiella Infections; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Sepsis; Serratia marcescens; Thienamycins | 1986 |
Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Drug Therapy, Combination; Female; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Penicillins; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Ticarcillin | 1986 |
Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients.
Topics: Adult; Aged; Agranulocytosis; Amikacin; Bacteria; Bacterial Infections; Clavulanic Acids; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Male; Middle Aged; Neoplasms; Penicillin Resistance; Penicillins; Sepsis; Ticarcillin | 1986 |
[Neonatal septicemia caused by Staphylococcus epidermidis].
Topics: Amikacin; Ampicillin; Dicloxacillin; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Male; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis | 1987 |
Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clofazimine; Cycloserine; Drug Therapy, Combination; Humans; Isoniazid; Lactams, Macrocyclic; Mycobacterium avium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis | 1987 |
Protective activity of habekacin and four other aminoglycosides in mouse septicaemia caused by Enterobacteriaceae.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Enterobacteriaceae Infections; Female; Gentamicins; Kanamycin; Male; Mice; Microbial Sensitivity Tests; Sepsis; Tobramycin | 1986 |
Clues to the early diagnosis of Mycobacterium avium-intracellulare infection in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Anti-Bacterial Agents; Clofazimine; Female; Humans; Lactams, Macrocyclic; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis | 1985 |
Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus.
Topics: Adult; Aged; Amikacin; Drug Combinations; Female; Humans; Male; Methicillin; Middle Aged; Penicillin Resistance; Sepsis; Staphylococcal Infections; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1985 |
Serum bactericidal activity as a therapeutic guide in severely granulocytopenic patients with gram-negative septicemia.
Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Combinations; Drug Synergism; Gram-Negative Bacteria; Humans; Kanamycin; Leukemia; Microbial Sensitivity Tests; Penicillins; Sepsis; Ticarcillin | 1985 |
Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Neutropenia; Penicillin Resistance; Peritonitis; Piperacillin; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis | 1985 |
Overview of first-line amikacin therapy for urologic infections.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Kidney Diseases; Lactams; Sepsis; Urinary Tract Infections | 1985 |
Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
Topics: Aged; Amikacin; Aminoglycosides; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Serratia marcescens | 1985 |
Neonatal septicemia due to Pseudomonas aeruginosa.
Topics: Adult; Amikacin; Ampicillin; Female; Humans; Infant, Newborn; Kanamycin; Male; Pregnancy; Pseudomonas Infections; Sepsis; Ticarcillin | 1986 |
Pseudomonas pseudomallei infection from drowning: the first reported case in Taiwan.
Topics: Amikacin; Bronchopneumonia; Cephalothin; Drowning; Drug Therapy, Combination; Female; Humans; Melioidosis; Middle Aged; Pseudomonas; Sepsis; Taiwan; Water Microbiology | 1985 |
[Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
Topics: Acinetobacter Infections; Adult; Aged; Amikacin; Bacterial Infections; Cystitis; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sepsis | 1985 |
Metabolite analysis in sepsis through conditional independence maps.
Topics: Adult; Aged; Algorithms; Bayes Theorem; Biomarkers; Carnitine; Computer Graphics; Critical Care; Female; Humans; Intensive Care Units; Isoleucine; Length of Stay; Male; Markov Chains; Metabolomics; Middle Aged; Models, Statistical; Patient Discharge; Probability; Prospective Studies; Sepsis; Shock, Septic | 2015 |